NEW YORK (GenomeWeb News) – For the second month in a row, shares of Myriad Genetics rose sharply, pacing gainers in the GenomeWeb Daily News Index.

The GWDN Index climbed 5 percent in February, outpacing the Down Jones Industrial Average (+ 4 percent) and matching the Nasdaq (+ 5 percent) for the month. However, it trailed the Nasdaq Biotech Index, which gained 8 percent month over month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.